These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 764975

  • 1. Combined immunotherapy in malignant melanoma. Regression of metastatic lesions in two patients concordant in timing with systemic administration of transfer factor and Bacillus Calmette-Guérin.
    Spitler LE, Levin AS, Wybran J.
    Cell Immunol; 1976 Jan; 21(1):1-19. PubMed ID: 764975
    [No Abstract] [Full Text] [Related]

  • 2. Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis.
    Spitler LE, Wong P, Sagebiel R.
    Arch Dermatol; 1978 Oct; 114(10):1501-4. PubMed ID: 718187
    [Abstract] [Full Text] [Related]

  • 3. Immunopathologic changes in patients with cutaneous malignant melanoma following intratumoral inoculation BCG: correlation with cell-mediated immunity.
    Lieberman R, Epstein W, Fudenberg HH.
    Int J Cancer; 1974 Sep 15; 14(3):401-16. PubMed ID: 4617711
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Complete remission of metastatic malignant melanoma following immunotherapy with Bacillus Calmette-Guerin (BCG): report of a case.
    Coates AS, Peters M.
    Aust N Z J Surg; 1977 Jun 15; 47(3):362-5. PubMed ID: 269705
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
    Cohen MH, Jessup JM, Felix EL, Weese JL, Herberman RB.
    Cancer; 1978 Jun 15; 41(6):2456-63. PubMed ID: 657108
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma.
    Pinsky CM, Hirshaut Y, Wanebo HJ, Fortner JG, Miké V, Schottenfeld D, Oettgen HF.
    Ann N Y Acad Sci; 1976 Jun 15; 277(00):187-94. PubMed ID: 1069548
    [No Abstract] [Full Text] [Related]

  • 14. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
    MacGregor AB, Falk RE, Landi S, Ambus U, Samuel ES, Langer B.
    Can J Surg; 1977 Jan 15; 20(1):25-30. PubMed ID: 832200
    [Abstract] [Full Text] [Related]

  • 15. Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
    McCulloch PB, Dent PB, Blajchman M, Muirhead WM, Price RA.
    Can Med Assoc J; 1977 Jul 09; 117(1):33-6. PubMed ID: 861909
    [Abstract] [Full Text] [Related]

  • 16. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU, Mavligit GM, Reed R, Burgess MA, Gottlieb J, Hersh EM.
    Cancer Treat Rep; 1976 Feb 09; 60(2):177-82. PubMed ID: 769970
    [Abstract] [Full Text] [Related]

  • 17. Calmette-Guerin bacillus treatment of experimental conjunctival malignant melanoma.
    Rutgard J, Peyman GA, Frenkel M, Saks S.
    Arch Ophthalmol; 1977 Dec 09; 95(12):2214-7. PubMed ID: 588117
    [Abstract] [Full Text] [Related]

  • 18. Chemoimmunotherapy of disseminated malignant melanoma with DTIC-BCG, transfer factor + melphalan.
    Schwarz MA, Gutterman JU, Burgess MA, Heilbrun LK, Murphy WK, Bodey GP, Stone E, Turner-Chism V, Hersh EM.
    Cancer; 1980 May 15; 45(10):2506-15. PubMed ID: 7378986
    [Abstract] [Full Text] [Related]

  • 19. Chemoimmunotherapy for metastatic malignant melanoma using vincristine (NSC-67574), DTIC (NSC-45388) and Bacillus Calmette-Guerin.
    Thatcher N, Blackledge G, Palmer MK, Crowther D.
    Eur J Cancer (1965); 1981 Apr 15; 17(4):465-9. PubMed ID: 7308256
    [No Abstract] [Full Text] [Related]

  • 20. Observations on the combined systemic administration of mixed bacterial vaccine, bacillus Calmette-Guerin, transfer factor, and lymphoblastoid lymphocytes to patients with cancer, 1974-1985.
    Waisbren BA.
    J Biol Response Mod; 1987 Feb 15; 6(1):1-19. PubMed ID: 3559626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.